Cleared Traditional

K914422 - DEVICES FOR VASCU INTERVENT ROTAT HEMOSTAT VALVE

K914422 is an FDA 510(k) clearance for DEVICES FOR VASCU INTERVENT ROTAT HEMOS..., manufactured by Devices For Vascular Intervention, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 76-day FDA review.

K914422 · Devices For Vascular Intervention, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1991
Decision
76d
Days
Class 2
Risk

K914422 is an FDA 510(k) clearance for the DEVICES FOR VASCU INTERVENT ROTAT HEMOSTAT VALVE. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Devices For Vascular Intervention, Inc. (Redwood City, US). The FDA issued a Cleared decision on December 18, 1991 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Devices For Vascular Intervention, Inc. devices

FDA 510(k) Submission Details - K914422

510(k) Number K914422 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 1991
Decision Date December 18, 1991
Days to Decision 76 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 125d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 830
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K914422.
TRACKER(R) UNIBODY CATH & TRACKER 25 CATH,MODIFIED
K915521 · Target Therapeutics · Mar 1992
CORDIS 6 FRENCH 0.062 I.D. PTCA GUIDING CATHTER
K915374 · Cordis Corp. · Feb 1992
CORDIS SHUTTLE CATHETER
K915777 · Cordis Corp. · Feb 1992
ITC GUIDING CATHETER
K913052 · Interventional Therapeutics Corp. · Nov 1991
SCIMED 8 FR. TRIGUIDEFLEX GUIDING CATHETERS
K913830 · Scimed Life Systems, Inc. · Nov 1991
ISOLATE INFUSION CATHETR SYSTEM
K913517 · Lake Region Mfg., Inc. · Nov 1991